Regadenoson Injection, Solution
Product Images NDC 36000-364

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 36000-364). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-3 (Carton 3)

This is a medication description for Regadenoson ERAT, an injection administered intravenously as a stress agent. The medication helps medical professionals evaluate the heart's blood flow using a radiopharmaceutical. It is a sterile, nonpyrogenic, preservative-free solution that must be discarded if unused. This medication is manufactured by Baxter Pharmaceutical Solutions and has a national drug code (NDC) number: 36000-364-01. The text also contains product details such as dosages, ingredients, storage instructions, and mixing/administration procedures. The last line seems to be a garbled text that cannot be read.*

FDA Label Image

Container-2 (Container 2)

This appears to be a medical label for a medication called Regadenoson, which is given via injection and used for pharmacologic stress only. The medication comes in a single-dose pre-filled syringe containing 5mL and is for intravenous use only. The label also includes identification numbers, including a product code of NDC 36000-364-01.*

FDA Label Image

Description-1 (Description 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.